{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:23:03Z","timestamp":1789928583972,"version":"4.0.1"},"reference-count":53,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genet. Mol. Biol."],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1590\/s1415-47572014000300003","type":"journal-article","created":{"date-parts":[[2014,9,20]],"date-time":"2014-09-20T20:45:55Z","timestamp":1411245955000},"page":"315-329","source":"Crossref","is-referenced-by-count":41,"title":["Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin America"],"prefix":"10.1590","volume":"37","author":[{"given":"Roberto","family":"Giugliani","sequence":"first","affiliation":[{"name":"Hospital de Clinicas de Porto Alegre, Brazil; Universidade Federal do Rio Grande do Sul, Brasil; Instituto Nacional de Gen\u00e9tica M\u00e9dica Populacional, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Luz Solano","family":"Villarreal","sequence":"additional","affiliation":[{"name":"Asociaci\u00f3n Colombiana de Neurolog\u00eda Infantil, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Araceli Arellano","family":"Valdez","sequence":"additional","affiliation":[{"name":"Instituto Mexicano del Seguro Social, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonieta Mahfoud","family":"Hawilou","sequence":"additional","affiliation":[{"name":"Instituto de Estudios Avanzados"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Guelbert","sequence":"additional","affiliation":[{"name":"Hospital de Ni\u00f1os, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz Norela Correa","family":"Garz\u00f3n","sequence":"additional","affiliation":[{"name":"La Misericordia University Hospital, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Martins","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Acosta","sequence":"additional","affiliation":[{"name":"Universidade Federal de Bahia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Francisco","family":"Cabello","sequence":"additional","affiliation":[{"name":"Universidad de Chile, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A\u00edda","family":"Lemes","sequence":"additional","affiliation":[{"name":"Hospital Italiano, Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara Lucia Schmitz Ferreira","family":"Santos","sequence":"additional","affiliation":[{"name":"Hospital Pequeno Pr\u00edncipe, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Amartino","sequence":"additional","affiliation":[{"name":"Hospital Universitario Austral, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejmg.2010.07.013","article-title":"First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: Case observations from the Hunter Outcome Survey (HOS)","volume":"53","author":"Alcalde-Martin C","year":"2010","journal-title":"Eur J Med Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbamcr.2008.12.001","article-title":"Lysosomal disorders: from storage to cellular damage","volume":"1793","author":"Ballabio A","year":"2009","journal-title":"Biochim Biophys Acta","ISSN":"https:\/\/id.crossref.org\/issn\/0167-4889","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ymgme.2013.08.002","article-title":"The relationship between anti-idursulfase antibody status and safety and efficacy outcomes in attenuated mucopolysaccharidosis II patients aged 5 years and older treated with intravenous idursulfase","volume":"110","author":"Barbier AJ","year":"2013","journal-title":"Mol Genet Metab","ISSN":"https:\/\/id.crossref.org\/issn\/1096-7192","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2174\/138920111795542714","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): clinical picture and treatment","volume":"12","author":"Beck M","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management","volume":"34","author":"Braunlin EA","year":"2011","journal-title":"J Inherit Metab Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0141-8955","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymgme.2011.02.018","article-title":"Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS)","volume":"103","author":"Burton BK","year":"2011","journal-title":"Mol Genet Metab","ISSN":"https:\/\/id.crossref.org\/issn\/1096-7192","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ymgme.2010.06.011","article-title":"Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II - data from the Hunter Outcome Survey","volume":"101","author":"Burton BK","year":"2010","journal-title":"Mol Genet Metab","ISSN":"https:\/\/id.crossref.org\/issn\/1096-7192","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cca.2006.03.029","article-title":"Twelve different enzyme assays on dried-blood filter paper samples for detection of patients with selected inherited lysosomal storage diseases","volume":"372","author":"Civallero G","year":"2006","journal-title":"Clin Chim Acta","ISSN":"https:\/\/id.crossref.org\/issn\/0009-8981","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/14656566.9.2.311","article-title":"Idursulfase for the treatment of mucopolysaccharidosis II","volume":"9","author":"Clarke LA","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ymgme.2012.05.003","article-title":"Biomarkers for the mucopolysaccharidoses: discovery and clinical utility","volume":"106","author":"Clarke LA","year":"2012","journal-title":"Mol Genet Metab","ISSN":"https:\/\/id.crossref.org\/issn\/1096-7192","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/clinchem\/35.7.1472","article-title":"Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: A rapid screening procedure for mucopolysaccharidoses","volume":"35","author":"de Jong JG","year":"1989","journal-title":"Clin Chem","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9147","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1373\/clinchem.2005.061838","article-title":"Detection of mucopolysaccharidosis type II by measurement of iduronate-2-sulfatase in dried blood spots and plasma samples","volume":"52","author":"Dean CJ","year":"2006","journal-title":"Clin Chem","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9147","issn-type":"print"},{"key":"ref14","first-page":"S124","article-title":"Novel treatments and future perspectives: outcomes of intrathecal drug delivery","volume":"1","author":"Dickson PI","year":"2009","journal-title":"Int J Clin Pharmacol Ther 47 Suppl"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/bjo.2010.179937","article-title":"Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis","volume":"95","author":"Ferrari S","year":"2011","journal-title":"Br J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1161","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1651-2227.2002.tb03116.x","article-title":"Mucopolysaccharidosis type II - genotype\/phenotype aspects","volume":"91","author":"Froissart R","year":"2002","journal-title":"Acta Paediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0001-656X","issn-type":"print"},{"key":"ref17","article-title":"A multi-center, open-label study evaluating safety and clinical outcomes in young children (1.4-7.5 years) with Hunter syndrome receiving idursulfase enzyme replacement therapy","author":"Giugliani R","year":"2013","journal-title":"Genet Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1745-7599.2010.00517.x","article-title":"Clinical practice guidelines for pediatric constipation","volume":"22","author":"Greenwald BJ","year":"2010","journal-title":"J Am Acad Nurse Pract","ISSN":"https:\/\/id.crossref.org\/issn\/1041-2972","issn-type":"print"},{"key":"ref19","first-page":"175","article-title":"Guideline for diagnosis, follow-up and treatment of mucopolysaccharidoses type II or Hunter disease","volume":"109","author":"Guelbert N","year":"2011","journal-title":"Arch Argent Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0004-0487","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2008.11.041","article-title":"Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years","volume":"154","author":"Guffon N","year":"2009","journal-title":"J Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3476","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpeds.2011.03.019","article-title":"Early clinical markers of central nervous system involvement in mucopolysaccharidosis type II","volume":"159","author":"Holt J","year":"2011","journal-title":"J Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3476","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e1258","DOI":"10.1542\/peds.2010-1274","article-title":"Natural progression of neurological disease in mucopolysaccharidosis type II","volume":"127","author":"Holt JB","year":"2011","journal-title":"Pediatrics","ISSN":"https:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.a.34415","article-title":"Mucopolysaccharidosis type II in females and response to enzyme replacement therapy","volume":"158A","author":"Jurecka A","year":"2012","journal-title":"Am J Med Genet A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10545-011-9378-5","article-title":"Hearing loss in patients with mucopolysaccharidosis II: data from HOS - the Hunter Outcome Survey","volume":"35","author":"Keilmann A","year":"2012","journal-title":"J Inherit Metab Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0141-8955","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10545-010-9254-8","article-title":"Heparin cofactor II-thrombin complex and dermatan sulphate: chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases","volume":"34","author":"Langford-Smith KJ","year":"2011","journal-title":"J Inherit Metab Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0141-8955","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.4081\/or.2010.e16","article-title":"on behalf of the HOS investigators (2010) Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey","volume":"2","author":"Link B","journal-title":"Orthop Rev","ISSN":"https:\/\/id.crossref.org\/issn\/0094-6591","issn-type":"print"},{"key":"ref27","first-page":"122","article-title":"The oral signs of Hurler-Hunter syndrome: report of four cases","volume":"47","author":"Liu KL","year":"1980","journal-title":"ASDC J Dent Child","ISSN":"https:\/\/id.crossref.org\/issn\/0022-0353","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/bit.23118","article-title":"Expression in CHO cells and pharmacokinetics and brain uptake in the Rhesus monkey of an IgG-iduronate-2-sulfatase fusion protein","volume":"108","author":"Lu JZ","year":"2011","journal-title":"Biotechnol Bioeng","ISSN":"https:\/\/id.crossref.org\/issn\/0006-3592","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome)","volume":"121","author":"Martin R","year":"2008","journal-title":"Pediatrics","ISSN":"https:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/GIM.0b013e3181f6e74d","article-title":"Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): Data from the Hunter Outcome Survey","volume":"12","author":"Mendelsohn NJ","year":"2010","journal-title":"Genet Med"},{"key":"ref31","first-page":"S100","article-title":"Management of infusion-related reactions to enzyme replacement therapy in a cohort of patients with mucopolysaccharidosis disorders","volume":"1)","author":"Miebach E","year":"2009","journal-title":"Int J Clin Pharmacol Ther 47 (suppl"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"330","DOI":"10.12968\/bjon.2006.15.6.20681","article-title":"Intravenous enzyme replacement therapy: better in home or hospital","volume":"15","author":"Milligan A","year":"2006","journal-title":"Br J Nurs","ISSN":"https:\/\/id.crossref.org\/issn\/0966-0461","issn-type":"print"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer J","year":"2006","journal-title":"Genet Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","article-title":"A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)","volume":"90","author":"Muenzer J","year":"2007","journal-title":"Mol Genet Metab","ISSN":"https:\/\/id.crossref.org\/issn\/1096-7192","issn-type":"print"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e1228","DOI":"10.1542\/peds.2008-0999","article-title":"Multidisciplinary management of Hunter syndrome","volume":"124","author":"Muenzer J","year":"2009","journal-title":"Pediatrics","ISSN":"https:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/GIM.0b013e318206786f","article-title":"Idursulfase treatment of Hunter syndrome in children younger than 6 years: results from the Hunter Outcome Survey","volume":"13","author":"Muenzer J","year":"2011","journal-title":"Genet Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00431-011-1606-3","article-title":"The role of enzyme replacement therapy in severe Hunter syndrome - an expert panel consensus","volume":"171","author":"Muenzer J","year":"2012","journal-title":"Eur J Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0340-6199","issn-type":"print"},{"key":"ref38","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"pp 3421","volume-title":"The mucopolysaccharidoses","volume":"III","author":"Neufeld EF","year":"2001","edition":"8th"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00003446-198407000-00009","article-title":"Hearing loss in Hunter's syndrome - Mucopolysaccharidosis II","volume":"5","author":"Peck JE","year":"1984","journal-title":"Ear Hear","ISSN":"https:\/\/id.crossref.org\/issn\/0196-0202","issn-type":"print"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","article-title":"Prevalence of lysosomal storage diseases in Portugal","volume":"12","author":"Pinto R","year":"2004","journal-title":"Eur J Hum Genet","ISSN":"https:\/\/id.crossref.org\/issn\/1018-4813","issn-type":"print"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","article-title":"Transplant outcomes in mucopolysaccharidoses","volume":"47","author":"Prasad VK","year":"2010","journal-title":"Semin Hematol","ISSN":"https:\/\/id.crossref.org\/issn\/0037-1963","issn-type":"print"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2008.05.001","article-title":"Heparin cofactor II-thrombin complex: a biomarker of MPS disease","volume":"94","author":"Randall DR","year":"2008","journal-title":"Mol Genet Metab","ISSN":"https:\/\/id.crossref.org\/issn\/1096-7192","issn-type":"print"},{"key":"ref43","series-title":"GeneReviews 1993-2007","volume-title":"Mucopolysaccharidosis type II","author":"Scarpa M","year":"2011"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-6-72","article-title":"Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease","volume":"6","author":"Scarpa M","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10545-010-9215-2","article-title":"Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II","volume":"34","author":"Schulze-Frenking G","year":"2011","journal-title":"J Inherit Metab Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0141-8955","issn-type":"print"},{"key":"ref46","series-title":"Elaprase\u00ae (idursulfase) solution for intravenous infusion [prescribing information]","year":"2011"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pediatrneurol.2004.10.009","article-title":"Mucopolysaccharidosis type II in females: case report and review of literature","volume":"32","author":"Tuschl K","year":"2005","journal-title":"Pediatr Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0887-8994","issn-type":"print"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1111\/j.1651-2227.2011.02385.x","article-title":"Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3-year follow-up","volume":"101","author":"Tylki-Szymanska A","year":"2012","journal-title":"Acta Paediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0001-656X","issn-type":"print"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/BF01800232","article-title":"Bone marrow transplantation for Sanfilippo disease type B","volume":"15","author":"Vellodi A","year":"1992","journal-title":"J Inherit Metab Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0141-8955","issn-type":"print"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","article-title":"Long-term follow-up following bone marrow transplantation for Hunter disease","volume":"22","author":"Vellodi A","year":"1999","journal-title":"J Inherit Metab Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0141-8955","issn-type":"print"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ajmg.a.32320","article-title":"Mucopolysaccharidoses in Brazil: what happens from birth to biochemical diagnosis","volume":"146A","author":"Vieira T","year":"2008","journal-title":"Am J Med Genet A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/GIM.0b013e31817701e6","article-title":"Initial report from the Hunter Outcome Survey","volume":"10","author":"Wraith JE","year":"2008","journal-title":"Genet Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith JE","year":"2008","journal-title":"Eur J Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0340-6199","issn-type":"print"}],"container-title":["Genetics and Molecular Biology"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/gmb\/v37n2\/a03v37n2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T18:53:05Z","timestamp":1598295185000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1415-47572014000300003&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1415-47572014000300003"],"URL":"https:\/\/doi.org\/10.1590\/s1415-47572014000300003","relation":{},"ISSN":["1415-4757"],"issn-type":[{"value":"1415-4757","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}